{ "cik": 907654, "cik_padded": "0000907654", "entityName": "Oruka Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001213900-26-026929", "filed": "2026-03-12", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 209000.0, "cash": 46935000.0, "free_cash_flow": -88419000.0, "net_income": -105433000.0, "operating_cash_flow": -88210000.0, "operating_income": -122051000.0, "stockholders_equity": 471930000.0, "total_assets": 488617000.0, "total_liabilities": 16687000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.035359057487339224, "roa_avg2y": -0.23836470593554862, "roa_period_end": -0.21577841131192735, "roe_avg2y": -0.24687204018961517, "roe_period_end": -0.2234081325620325 } }, { "accn": "0001213900-26-026929", "filed": "2026-03-12", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 189000.0, "cash": 61575000.0, "eps_diluted": -3.87, "free_cash_flow": -58026000.0, "net_income": -83724000.0, "operating_cash_flow": -57837000.0, "operating_income": -88123000.0, "stockholders_equity": 382221000.0, "total_assets": 396019000.0, "total_liabilities": 13798000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.03609953403920768, "roa_avg2y": -0.3859315939891214, "roa_period_end": -0.21141409881849105, "roe_avg2y": -0.3994075006976894, "roe_period_end": -0.21904604927515756 } }, { "accn": "0000950170-24-009809", "filed": "2024-02-01", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 37431000.0, "eps_diluted": -0.37, "free_cash_flow": -5014000.0, "net_income": -5339000.0, "operating_cash_flow": -5014000.0, "operating_income": -7296000.0, "stockholders_equity": 37020000.0, "total_assets": 37861000.0, "total_liabilities": 841000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.022717450027012427, "roa_avg2y": -0.13191510389642477, "roa_period_end": -0.14101582102955548, "roe_avg2y": -0.13569186585846263, "roe_period_end": -0.14421934089681254 } }, { "accn": "0000950170-24-009809", "filed": "2024-02-01", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2000.0, "cash": 42445000.0, "eps_diluted": -0.69, "free_cash_flow": -10914000.0, "net_income": -9926000.0, "operating_cash_flow": -10912000.0, "operating_income": -10596000.0, "stockholders_equity": 41673000.0, "total_assets": 43085000.0, "total_liabilities": 1412000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.03388284980682936, "roa_avg2y": -0.20255282678121397, "roa_period_end": -0.23038180341186026, "roe_avg2y": -0.2141162258941283, "roe_period_end": -0.23818779545509083 } }, { "accn": "0000950170-24-009809", "filed": "2024-02-01", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 43000.0, "cash": 53359000.0, "eps_diluted": -1.39, "free_cash_flow": -18805000.0, "net_income": -19322000.0, "operating_cash_flow": -18762000.0, "operating_income": -19335000.0, "stockholders_equity": 51043000.0, "total_assets": 54924000.0, "total_liabilities": 3881000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.07603393217483298, "roa_avg2y": -0.3668049319905461, "roa_period_end": -0.35179520792367636, "roe_avg2y": -0.3960887212496413, "roe_period_end": -0.37854358090237644 } }, { "accn": "0001564590-22-010075", "filed": "2023-02-24", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 19000.0, "cash": 49071000.0, "free_cash_flow": -7744000.0, "net_income": -9738000.0, "operating_cash_flow": -7725000.0, "operating_income": -9766000.0, "stockholders_equity": 46521000.0, "total_assets": 50429000.0, "total_liabilities": 3908000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08400507297779497, "roa_avg2y": -0.3302976341897736, "roa_period_end": -0.19310317476055444, "roe_avg2y": -0.359793833478044, "roe_period_end": -0.2093248210485587 } }, { "accn": "0001564590-22-010075", "filed": "2022-03-14", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4000.0, "cash": 8363000.0, "free_cash_flow": -4805000.0, "net_income": -5482000.0, "operating_cash_flow": -4801000.0, "operating_income": -5814000.0, "stockholders_equity": 7610000.0, "total_assets": 8536000.0, "total_liabilities": 926000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12168199737187911, "roa_avg2y": -0.7137556148688237, "roa_period_end": -0.6422211808809748, "roe_avg2y": -0.8036944729511801, "roe_period_end": -0.7203679369250986 } }, { "accn": "0001564590-21-014148", "filed": "2021-03-18", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4000.0, "cash": 6608000.0, "free_cash_flow": -8248000.0, "net_income": -7933000.0, "operating_cash_flow": -8244000.0, "operating_income": -8118000.0, "stockholders_equity": 6032000.0, "total_assets": 6825000.0, "total_liabilities": 793000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1314655172413793, "roa_avg2y": -0.8267847837415321, "roa_period_end": -1.1623443223443224, "roe_avg2y": -0.9729563990924143, "roe_period_end": -1.3151525198938991 } }, { "accn": "0001564590-20-005032", "filed": "2020-02-18", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3000.0, "cash": 8702000.0, "free_cash_flow": -17475000.0, "net_income": -18490000.0, "operating_cash_flow": -17472000.0, "operating_income": -18712000.0, "stockholders_equity": 10275000.0, "total_assets": 12365000.0, "total_liabilities": 2090000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.20340632603406325, "roa_avg2y": -0.999621560253014, "roa_period_end": -1.495349777598059, "roe_avg2y": -1.1389325202500846, "roe_period_end": -1.799513381995134 } }, { "accn": "0001564590-19-004882", "filed": "2019-02-27", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 12000.0, "cash": 7401000.0, "net_income": -16444000.0, "operating_income": -16613000.0, "stockholders_equity": 22194000.0, "total_assets": 24629000.0, "total_liabilities": 2435000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.10971433720825448, "roa_period_end": -0.6676681960290715, "roe_period_end": -0.740920969631432 } }, { "accn": "0001564590-14-000934", "filed": "2014-03-20", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "operating_cash_flow": "USD" }, "fundamentals": { "operating_cash_flow": -5288000.0 }, "period_end": "2013-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001213900-26-026929", "filed": "2026-03-12", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000907654.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000907654.json" }, "ticker": "ORKA" }